The Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies at Instituto Oswaldo Cruz (IOC/Fiocruz) is part of the new cooperation network of the World Health Organization (WHO) to monitor different types of coronavirus.
Called CoViNet, the initiative is an offshoot of the network of reference laboratories established by the WHO at the beginning of the public health emergency caused by SARS-CoV-2. The group brings together 36 laboratories from 21 countries with expertise in coronavirus surveillance in humans, animals and the environment.
The main objective of the new network is to expand the scope of surveillance beyond SARS-CoV-2, coordinating global efforts for the early detection, monitoring and evaluation of other coronaviruses, such as MERS-CoV, and possible new strains that may pose risks to health. public health.
The data generated by CoViNet will guide the work of the Organization's Technical Advisory Groups on Viral Evolution (TAG-VE) and Vaccine Composition (TAG-CO-VAC), ensuring that global health policies and tools are based on scientific information most recent and accurate.
O Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies do IOC [formerly the Measles and Respiratory Virus Laboratory] has collaborated for more than six decades with the WHO in the surveillance of respiratory viruses.
Before confirming the circulation of SARS-CoV-2 in the national territory, the Laboratory had already established the diagnostic procedure to be used in Brazil and trained teams from several states, in partnership with the Ministry of Health, and from countries in Latin America. , together with the Pan American Health Organization (PAHO/WHO). [Read more].
With the advancement of the pandemic, the Laboratory was designated a WHO reference for SARS-CoV-2 and its head, Marilda Siqueira, was one of the scientists invited to TAG-VE, a select group of researchers who advise the Organization on viral evolution.
In generating data on the genome of SARS-CoV-2 in Brazil, the Laboratory integrates the Genomic Network Fiocruzi, a project that brings together experts from all units of the Foundation and partner institutions to monitor the lineages and genetic mutations of the new coronavirus and contribute to better preparing the country to face the pandemic in terms of more accurate diagnosis and effective vaccines.
The Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies at Instituto Oswaldo Cruz (IOC/Fiocruz) is part of the new cooperation network of the World Health Organization (WHO) to monitor different types of coronavirus.
Called CoViNet, the initiative is an offshoot of the network of reference laboratories established by the WHO at the beginning of the public health emergency caused by SARS-CoV-2. The group brings together 36 laboratories from 21 countries with expertise in coronavirus surveillance in humans, animals and the environment.
The main objective of the new network is to expand the scope of surveillance beyond SARS-CoV-2, coordinating global efforts for the early detection, monitoring and evaluation of other coronaviruses, such as MERS-CoV, and possible new strains that may pose risks to health. public health.
The data generated by CoViNet will guide the work of the Organization's Technical Advisory Groups on Viral Evolution (TAG-VE) and Vaccine Composition (TAG-CO-VAC), ensuring that global health policies and tools are based on scientific information most recent and accurate.
O Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies do IOC [formerly the Measles and Respiratory Virus Laboratory] has collaborated for more than six decades with the WHO in the surveillance of respiratory viruses.
Before confirming the circulation of SARS-CoV-2 in the national territory, the Laboratory had already established the diagnostic procedure to be used in Brazil and trained teams from several states, in partnership with the Ministry of Health, and from countries in Latin America. , together with the Pan American Health Organization (PAHO/WHO). [Read more].
With the advancement of the pandemic, the Laboratory was designated a WHO reference for SARS-CoV-2 and its head, Marilda Siqueira, was one of the scientists invited to TAG-VE, a select group of researchers who advise the Organization on viral evolution.
In generating data on the genome of SARS-CoV-2 in Brazil, the Laboratory integrates the Genomic Network Fiocruzi, a project that brings together experts from all units of the Foundation and partner institutions to monitor the lineages and genetic mutations of the new coronavirus and contribute to better preparing the country to face the pandemic in terms of more accurate diagnosis and effective vaccines.
The non-profit reproduction of the text is allowed as long as the source is cited (Comunicação / Instituto Oswaldo Cruz)
 |
 |
